Skip to main content
Top
Published in: Abdominal Radiology 4/2008

01-07-2008

Cavernous transformation of the portal vein: three-dimensional dynamic contrast-enhanced MR angiography

Authors: Li Wang, Zhao-shen Li, Jian-ping Lu, Fei Wang, Qi Liu, Jian-ming Tian

Published in: Abdominal Radiology | Issue 4/2008

Login to get access

Abstract

Background

To investigate characteristic features of three-dimensional dynamic contrast-enhanced MR angiography (3D DCE-MRA) and validate its clinical significance for the diagnosis of cavernous transformation of the portal vein (CTPV).

Methods

3D DCE-MRA, along with subsequent data processing using three-dimensional reconstruction, was performed in 33 CTPV patients. We observed 33 emboli in the portal vein, 29 in the left and/or right portal branches, 18 in the superior mesenteric vein, and nine emboli in the splenic vein.

Results

The main presentation of CTPV on 3D DCE-MRA was the replacement of the normal configuration of the portal vein by numerous distorted hepatopetal collateral vessels, the presence of arterio-portal venous shunts, and the appearance of hepatofugal collateral vessels in the abdominal cavity and wall.

Conclusion

3D DCE-MRA can be used to simultaneously characterize the portal system and collateral vessels, and can improve the diagnosis and clinical treatment of CTPV.
Literature
1.
go back to reference Rossi S, Rosa L, Ravetta V, et al. (2006) Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems AJR Am J Roentgenol 186:763–773PubMedCrossRef Rossi S, Rosa L, Ravetta V, et al. (2006) Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems AJR Am J Roentgenol 186:763–773PubMedCrossRef
2.
go back to reference Vilgrain V, Condat B, Bureau C, et al. (2006) Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation Radiology 241:149–155PubMedCrossRef Vilgrain V, Condat B, Bureau C, et al. (2006) Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation Radiology 241:149–155PubMedCrossRef
3.
go back to reference Baker ME, Remzi F, Einstein D, et al. (2003) CT depiction of portal vein thrombi after creation of ileal pouch-anal anastomosis Radiology 227:73–79PubMedCrossRef Baker ME, Remzi F, Einstein D, et al. (2003) CT depiction of portal vein thrombi after creation of ileal pouch-anal anastomosis Radiology 227:73–79PubMedCrossRef
4.
go back to reference Sakata H, Konishi M, Ryu M, et al. (2004) Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus Hepatogastroenterology 51:1575–1580PubMed Sakata H, Konishi M, Ryu M, et al. (2004) Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus Hepatogastroenterology 51:1575–1580PubMed
5.
go back to reference Shinohara T, Ando H, Watanabe Y, et al. (2006) Extrahepatic portal vein morphology in children with extrahepatic portal hypertension assessed by 3-dimensional computed tomographic portography: a new etiology of extrahepatic portal hypertension J Pediatr Surg 41:812–816PubMedCrossRef Shinohara T, Ando H, Watanabe Y, et al. (2006) Extrahepatic portal vein morphology in children with extrahepatic portal hypertension assessed by 3-dimensional computed tomographic portography: a new etiology of extrahepatic portal hypertension J Pediatr Surg 41:812–816PubMedCrossRef
6.
go back to reference Gallego C, Velasco M, Marcuello P, et al. (2002) Congenital and acquired anomalies of the portal venous system Radiographics 22:141–159PubMed Gallego C, Velasco M, Marcuello P, et al. (2002) Congenital and acquired anomalies of the portal venous system Radiographics 22:141–159PubMed
7.
go back to reference Sheen CL, Lamparelli H, Milne A et al. (2000) Clinical features, diagnosis and outcome of acute portal vein thrombosis QJM 93:531–534PubMedCrossRef Sheen CL, Lamparelli H, Milne A et al. (2000) Clinical features, diagnosis and outcome of acute portal vein thrombosis QJM 93:531–534PubMedCrossRef
8.
go back to reference Kreft B, Strunk H, Flacke S, et al. (2000) Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography Radiology 216:86–92PubMed Kreft B, Strunk H, Flacke S, et al. (2000) Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography Radiology 216:86–92PubMed
9.
go back to reference Lupescu I, Masala N, Capsa R, et al. (2006) CT and MRI of acquired portal venous system anomalies J Gastrointestin Liver Dis 15:393–398PubMed Lupescu I, Masala N, Capsa R, et al. (2006) CT and MRI of acquired portal venous system anomalies J Gastrointestin Liver Dis 15:393–398PubMed
10.
go back to reference Miniati DN, Padidar AM, Kee ST, et al. (2005) Portal vein thrombosis after laparoscopic splenectomy: an ongoing clinical challenge JSLS 9:335–338PubMed Miniati DN, Padidar AM, Kee ST, et al. (2005) Portal vein thrombosis after laparoscopic splenectomy: an ongoing clinical challenge JSLS 9:335–338PubMed
11.
go back to reference Jiang ZB, Shan H, Shen XY, et al. (2004) Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis World J Gastroenterol 10:1881–1884PubMed Jiang ZB, Shan H, Shen XY, et al. (2004) Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis World J Gastroenterol 10:1881–1884PubMed
12.
go back to reference Higa M, Kojima M, Ohnuma S, et al. (2001) Portal and mesenteric vein and inferior vena cava thrombosis associated with antiphospholipid syndrome Intern Med 40:1245–1249PubMedCrossRef Higa M, Kojima M, Ohnuma S, et al. (2001) Portal and mesenteric vein and inferior vena cava thrombosis associated with antiphospholipid syndrome Intern Med 40:1245–1249PubMedCrossRef
13.
go back to reference Smith TM, Semelka RC, Noone TC, et al. (1999) Islet cell tumor of the pancreas associated with tumor thrombus in the portal vein Magn Reson Imaging 17:1093–1096PubMedCrossRef Smith TM, Semelka RC, Noone TC, et al. (1999) Islet cell tumor of the pancreas associated with tumor thrombus in the portal vein Magn Reson Imaging 17:1093–1096PubMedCrossRef
14.
go back to reference Gurakan F, Eren M, Kocak N, et al. (2004) Extrahepatic portal vein thrombosis in children: etiology and long-term follow-up J Clin Gastroenterol 38:368–372PubMedCrossRef Gurakan F, Eren M, Kocak N, et al. (2004) Extrahepatic portal vein thrombosis in children: etiology and long-term follow-up J Clin Gastroenterol 38:368–372PubMedCrossRef
15.
go back to reference Egesel T, Buyukasik Y, Dundar SV, et al. (2000) The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis J Clin Gastroenterol 30:66–71PubMedCrossRef Egesel T, Buyukasik Y, Dundar SV, et al. (2000) The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis J Clin Gastroenterol 30:66–71PubMedCrossRef
16.
go back to reference Gauthier-Villars M, Franchi S, Gauthier F, et al. (2005) Cholestasis in children with portal vein obstruction J Pediatr 146:568–573PubMedCrossRef Gauthier-Villars M, Franchi S, Gauthier F, et al. (2005) Cholestasis in children with portal vein obstruction J Pediatr 146:568–573PubMedCrossRef
17.
go back to reference Bilbao JI, Elorz M, Vivas I, et al. (2004) Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients Cardiovasc Intervent Radiol JT Cardiovasc Intervent Radiol 27:474–480 Bilbao JI, Elorz M, Vivas I, et al. (2004) Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients Cardiovasc Intervent Radiol JT Cardiovasc Intervent Radiol 27:474–480
18.
go back to reference Amitrano L, Guardascione MA, Brancaccio V, et al. (2004) Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis J Hepatol 40:736–741PubMedCrossRef Amitrano L, Guardascione MA, Brancaccio V, et al. (2004) Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis J Hepatol 40:736–741PubMedCrossRef
19.
go back to reference Hidajat N, Stobbe H, Griesshaber V, et al. (2005) Portal vein thrombosis: etiology, diagnostic strategy, therapy and management Vasa 34:81–92PubMedCrossRef Hidajat N, Stobbe H, Griesshaber V, et al. (2005) Portal vein thrombosis: etiology, diagnostic strategy, therapy and management Vasa 34:81–92PubMedCrossRef
20.
go back to reference Ide T, Ohno Y, Nakanuma Y, et al. (2003) Early development of cavernomatous vasculatures in portal venous thrombosis: morphometric kinetics in rabbit model. Hepatol Res 27:136–142PubMedCrossRef Ide T, Ohno Y, Nakanuma Y, et al. (2003) Early development of cavernomatous vasculatures in portal venous thrombosis: morphometric kinetics in rabbit model. Hepatol Res 27:136–142PubMedCrossRef
Metadata
Title
Cavernous transformation of the portal vein: three-dimensional dynamic contrast-enhanced MR angiography
Authors
Li Wang
Zhao-shen Li
Jian-ping Lu
Fei Wang
Qi Liu
Jian-ming Tian
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 4/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9292-3

Other articles of this Issue 4/2008

Abdominal Radiology 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.